Patent Intelligence Brand Launched With 37 New Ways To Analyse Pharmaceutical Data
Pharmaceutical patent intelligence specialist GenericsWeb today launched a new brand and a major upgrade to its patent intelligence product line.
SYDNEY, AUSTRALIA, February 06, 2014 /24-7PressRelease/ -- Pharmaceutical patent intelligence specialist GenericsWeb today launched a new brand and a major upgrade to its patent intelligence product line.
Called ARK Patent Intelligence, the product makes it easier than ever to spot intellectual property (IP) opportunities and risks because it lets pharmaceutical IP professionals to interpret data in completely new ways.
GenericsWeb CEO, Leighton Howard said:
"Because it's so easy to use, ARK Patent Intelligence transforms the way people interact with complex information.
We've noticed IP professionals using ARK often become more "playful" and find new ways to visualise and explore their patent landscape. That's going to unlock a lot of value for their company, but it also makes their work far more personally rewarding."
ARK Patent Intelligence has a user interface designed specifically for IP decision makers in the pharmaceutical sector. The product itself is based on data from Pipeline Patent Intelligence, an industry intelligence platform researched and updated for 10 years by GenericsWeb.
"When you use ARK, analysing complex data becomes second nature and really very easy. To a user it feels like moving from an old cell-phone to a modern smart-phone.
ARK uses the high-quality data all pharmaceutical IP professionals require, but it saves them time and lets them focus on critical analysis and discovery" said Howard.
Some features of the ARK Patent Intelligence product are:
- Graphic display of generic drug launch opportunities makes opportunity identification easier
- Intuitive user interface makes it easy for IP professionals to manipulate data in new ways
- Constraint commentary and analysis make IP data more usable, even by non-patent-experts
GenericsWeb is a global provider of data for the pharmaceutical sector and provides IP solutions to pharmaceutical firms in every continent. It currently supplies data to 8 of the top 10 generics firms in the world. GenericsWeb is also responsible for a series of SPC validity studies that have uncovered a string of critical SPC protection issues across Europe since 2011.
ARK PATENT INTELLIGENCE data linked by INN includes: key patent, extension, data exclusivity, non-patent literature, marketing authorisations, dossiers, news and more. Data is linked and indexed by international non-proprietary name (INN) to ensure data integrity and reduce the risk of missed data.
Disclaimer: If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.